Literature DB >> 2407225

Carcinoembryonic antigen enhances metastatic potential of human colorectal carcinoma.

R B Hostetter1, D E Campbell, K F Chi, S Kerckhoff, K R Cleary, S Ullrich, P Thomas, J M Jessup.   

Abstract

Patients with human colorectal carcinoma have a poor prognosis when serum carcinoembryonic antigen level exceeds 5 ng/mL. The hypothesis that carcinoembryonic antigen enhances metastasis by promoting the attachment of tumor cells to Kupffer cells and hepatocytes was tested in an experimental metastasis model in which colorectal carcinoma cells were injected into the spleens of BALB/c athymic nude mice and liver colonies counted 5 weeks later. Pretreatment with systemic injections of carcinoembryonic antigen significantly increased the metastatic potential of a poorly metastatic colorectal carcinoma cell line KM-12c, but did not induce the nonmetastatic colorectal carcinoma cell line HC 2998 to produce metastases, nor did carcinoembryonic antigen make the highly metastatic colorectal carcinoma cell line mHC 1410 more metastatic. Carcinoembryonic antigen did not stimulate proliferation of colorectal carcinoma but appeared to be a cofactor for metastasis possibly as an adhesion factor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407225     DOI: 10.1001/archsurg.1990.01410150022004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  16 in total

Review 1.  The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion.

Authors:  M A Kerr; S C Stocks
Journal:  Histochem J       Date:  1992-11

2.  Immunophenotyping of human HT29 colon cancer cell primary tumours and their metastases in severe combined immunodeficient mice.

Authors:  B S Mitchell; H P Horny; U Schumacher
Journal:  Histochem J       Date:  1997-05

3.  A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver.

Authors:  James L Gulley; Ravi A Madan; Kwong-Yok Tsang; Philip M Arlen; Kevin Camphausen; Mahsa Mohebtash; Mitchell Kamrava; Jeffrey Schlom; Deborah Citrin
Journal:  Expert Opin Biol Ther       Date:  2011-08-28       Impact factor: 4.388

4.  SSO Clinical Award Lecture. The surgical oncologist as a key translator of basic biology to patients with gastrointestinal cancer: asking the right questions.

Authors:  G Steele
Journal:  Ann Surg Oncol       Date:  1994-05       Impact factor: 5.344

Review 5.  Current concepts in metastasis.

Authors:  A K Nigam; M Pignatelli; P B Boulos
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

6.  Identification of CEACAM5 as a Biomarker for Prewarning and Prognosis in Gastric Cancer.

Authors:  Jinfeng Zhou; Xing Fan; Ning Chen; Fenli Zhou; Jiaqiang Dong; Yongzhan Nie; Daiming Fan
Journal:  J Histochem Cytochem       Date:  2015-09-15       Impact factor: 2.479

7.  A 10-year survivor with unresectable hepatic metastases from sigmoid colon carcinoma treated with regional chemotherapy.

Authors:  S Takeda; K Hisatomi; S Nakano; K Okamoto; Y Nagafuchi; H Itoh; K Ohsato
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells.

Authors:  Cary B Aarons; Olga Bajenova; Charles Andrews; Stanley Heydrick; Kristen N Bushell; Karen L Reed; Peter Thomas; James M Becker; Arthur F Stucchi
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

9.  Biliary glycoprotein is overexpressed in human colon cancer cells with high metastatic potential.

Authors:  T J Yeatman; W Mao; R C Karl
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

10.  Classification and localisation of carcinoembryonic antigen (CEA) related antigen expression in normal oesophageal squamous mucosa and squamous carcinoma.

Authors:  D S Sanders; C A Wilson; F J Bryant; J Hopkins; G D Johnson; D M Milne; M A Kerr
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.